THE global market for nuclear medicine is poised for growth, and SA plans to play a major role.

NTP Radioisotopes SOC, a subsidiary of the SA Nuclear Energy Corp (Necsa) that produces radioactive chemicals used to make nuclear medicine, is preparing to more than double in size over the next few years. The group already commands 25% of the global market, supplying 55 countries.